GlobeNewswire Inc.··NaAssembly Biosciences to Showcase Herpes Treatment Data at Major Healthcare Conference
Assembly Biosciences will present positive Phase 1b herpes treatment data at BofA Securities conference in May 2026, with CMO presenting findings on experimental antivirals.
GILDASMBbiotechnologyhepatitis B